Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial

American Heart Journal

Volumn 144, Issue 3, 2002, Pages 478-484

  Brodsky, Michael A ^a   Mitchell, L Brent ^b   Halperin, Blair D ^c   Raitt, Merritt H ^c,d   Hallstrom, Alfred P ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DEATH; DEFIBRILLATOR; ELECTROPHYSIOLOGY; EVALUATION; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SYNCOPE;

EID: 0036733448     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.125502     Document Type: Article

References (29)

1. Electrical stimulation of the heart in patients with ventricular tachycardia
2. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs
3. Out-of-hospital cardiac arrest: Electrophysiologic observations and selection of long-term antiarrhythmic therapy
4. Management of survivors of cardiac arrest: Is electrophysiologic testing obsolete in the era of implantable defibrillators?
5. The value of electrophysiologic testing in patients resuscitated from documented ventricular fibrillation
6. Is a baseline electrophysiologic study mandatory for the management of patients with spontaneous, sustained ventricular tachyarrhythmias?
7. Management of ventricular fibrillation with transvenous defibrillators without baseline electrophysiologic testing or antiarrhythmic drugs
8. Antiarrhythmics Versus Implantable Defibrillators (AVID): Rationale, design, and methods
9. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
10. Out-of-hospital cardiac arrest: Use of electrophysiologic testing in the prediction of long-term outcome
11. Clinical features and prognosis of patients with out of hospital cardiac arrest and a normal electrophysiologic study
12. The long-term prognosis of patients with out-of-hospital cardiac arrest but no inducible ventricular tachycardia
13. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: Evaluation by electrophysiologic subgroups
14. ICD implantation: Cost conscious or patient conscious
15. Surgical coronary revascularization in survivors of in-hospital cardiac arrest: Its affect on inducible arrhythmias and long term survival
16. Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation
17. Life-threatening ventricular arrhythmias due to transient or correctable causes: High risk for death in follow-up
18. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation: Implications for use of implantable defibrillator
19. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients
20. Ventricular resection guided by epicardial and endocardial mapping for treatment of recurrent ventricular tachycardia
21. Bundle branch reentrant ventricular tachycardia: Cumulative experience in 48 patients
22. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator
23. Patients with supraventricular tachycardia presenting with aborted sudden death: Incidence, mechanism and long-term follow-up
24. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
25. Determinants of induced sustained arrhythmias in survivors of out-of-hospital ventricular fibrillation
26. Secondary prevention of sudden death
27. Risks and complications of clinical cardiac electrophysiologic studies: A prospective analysis of 1,000 consecutive patients
28. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias: The multicenter automatic defibrillator implantation trial (MADIT)
29. Multicenter automatic defibrillator implantation trial II (MADIT II): Design and clinical protocol